ZA200703603B - Macrolones - amino substituted quinolones - Google Patents

Macrolones - amino substituted quinolones Download PDF

Info

Publication number
ZA200703603B
ZA200703603B ZA200703603A ZA200703603A ZA200703603B ZA 200703603 B ZA200703603 B ZA 200703603B ZA 200703603 A ZA200703603 A ZA 200703603A ZA 200703603 A ZA200703603 A ZA 200703603A ZA 200703603 B ZA200703603 B ZA 200703603B
Authority
ZA
South Africa
Prior art keywords
dihydro
oxo
carboxy
dimethylamino
erythromycin
Prior art date
Application number
ZA200703603A
Other languages
English (en)
Inventor
Best Desmond John
Elder John Stephen
Fajdetic Andrea
Forrest Andrew Keith
Sheppard Robert John
Original Assignee
Glaxo Group Ltd
Glaxosmithkline Zagreb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Glaxosmithkline Zagreb filed Critical Glaxo Group Ltd
Publication of ZA200703603B publication Critical patent/ZA200703603B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA200703603A 2004-11-11 2007-05-04 Macrolones - amino substituted quinolones ZA200703603B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0424959A GB0424959D0 (en) 2004-11-11 2004-11-11 Novel compounds

Publications (1)

Publication Number Publication Date
ZA200703603B true ZA200703603B (en) 2008-07-30

Family

ID=33523587

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200703603A ZA200703603B (en) 2004-11-11 2007-05-04 Macrolones - amino substituted quinolones

Country Status (19)

Country Link
US (2) US7718621B2 (fr)
EP (1) EP1824870A1 (fr)
JP (1) JP2008519788A (fr)
KR (1) KR20070085919A (fr)
CN (1) CN101098881A (fr)
AR (1) AR053311A1 (fr)
AU (1) AU2005303961A1 (fr)
BR (1) BRPI0517792A (fr)
CA (1) CA2587413A1 (fr)
GB (1) GB0424959D0 (fr)
IL (1) IL182978A0 (fr)
MA (1) MA29213B1 (fr)
MX (1) MX2007005776A (fr)
NO (1) NO20072939L (fr)
PE (1) PE20061137A1 (fr)
RU (1) RU2007121581A (fr)
TW (1) TW200630378A (fr)
WO (1) WO2006050942A1 (fr)
ZA (1) ZA200703603B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2772254A3 (fr) 2003-03-10 2015-03-11 Optimer Pharmaceuticals, Inc. Nouveaux agents antibactériens
US20080312167A1 (en) * 2005-05-10 2008-12-18 Sulejman Alihodzic 4'' Amino Linked Macrolides Useful for the Treatment of Microbial Infections
EP1945652A1 (fr) * 2005-11-09 2008-07-23 Glaxo Group Limited Macrolones
EP1951735A1 (fr) * 2005-11-09 2008-08-06 Glaxo Group Limited Nouveau dérivé 4*substitué d' érythromycine
AU2008298545B2 (en) 2007-09-14 2013-12-12 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
CN102245195B (zh) 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ,インコーポレイテッド マラリア、結核、及びmac病の治療方法
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
AU2013239696C1 (en) 2012-03-27 2018-11-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
EP2968801B1 (fr) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Procédés pour traiter des maladies respiratoires et formulations pour la mise en oeuvre de ceux-ci
EP2968384A4 (fr) 2013-03-15 2017-02-15 Cempra Pharmaceuticals, Inc. Procédés convergents de préparation d'agents antibactériens macrolides
CN106589023A (zh) * 2016-11-22 2017-04-26 宜昌东阳光药业股份有限公司 一种罗红霉素杂质及其合成方法
JP7344125B2 (ja) 2017-03-30 2023-09-13 エフ. ホフマン-ラ ロシュ アーゲー 細菌感染の治療及び予防のための新規ピリド[2,3-b]インドール化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
JP2008519788A (ja) 2008-06-12
NO20072939L (no) 2007-08-08
US20080269146A1 (en) 2008-10-30
AR053311A1 (es) 2007-05-02
MX2007005776A (es) 2007-07-16
RU2007121581A (ru) 2008-12-20
BRPI0517792A (pt) 2008-10-21
GB0424959D0 (en) 2004-12-15
WO2006050942A1 (fr) 2006-05-18
US7718621B2 (en) 2010-05-18
AU2005303961A1 (en) 2006-05-18
IL182978A0 (en) 2007-08-19
CN101098881A (zh) 2008-01-02
EP1824870A1 (fr) 2007-08-29
CA2587413A1 (fr) 2006-05-18
TW200630378A (en) 2006-09-01
US20080090773A1 (en) 2008-04-17
MA29213B1 (fr) 2008-02-01
PE20061137A1 (es) 2006-12-13
KR20070085919A (ko) 2007-08-27

Similar Documents

Publication Publication Date Title
ZA200703603B (en) Macrolones - amino substituted quinolones
EP1756135B1 (fr) Macrolides a liason ester utiles pour le traitement d'infections microbiennes
US20090111760A1 (en) Macrolone compounds
EP1628989B1 (fr) Nouveaux composes a cycle ramifie en 14 et 15
EP1628988B1 (fr) Nouveau composes a cycle ramifie en 14 et 15.
US20090062218A1 (en) Macrolone compounds
CA2525449A1 (fr) Macrolides substitues en position 4''
EP1628990B1 (fr) Nouveaux composes cycliques de 14 et de 15 chainons
WO2004101589A1 (fr) Nouveaux composes cycliques a 14 ou 15 chainons
EP1633765B1 (fr) Nouveaux composes a cycles a 14 et 15 elements
US20080096829A1 (en) Macrolone Compounds
EP1879904A1 (fr) Macrolides a liaison aminee 4" destines au traitement d'infections microbiennes
EP1756134A1 (fr) Macrolides a liaison carbamate utilises dans le traitement des infections microbiennes
WO2004101584A1 (fr) Macrolides substitues en position 3 possedant une activite antimicrobienne
WO2007054295A1 (fr) Nouveau dérivé 4*substitué d’érythromycine